• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

AcelRx Pharmaceuticals Inc

+ Add to Watchlist


10.4700 USD 0.2400 2.35%

As of 12:14:31 ET on 04/17/2014.

Snapshot for AcelRx Pharmaceuticals Inc (ACRX)

Open: 10.4500 Day's Range: 10.0200 - 10.6000 Volume: 377,196
Previous Close: 10.2300 52wk Range: 5.3500 - 13.6400 1-Yr Rtn: +91.04%

Stock Chart for ACRX

No chart data available.
  • ACRX:US 10.4700
  • 1D
  • 1M
  • 1Y
Interactive ACRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6419
Est. EPS (USD) (12/2014) -0.9790
Est. PEG Ratio -
Market Cap (M USD) 453.40
Shares Outstanding (M) 43.18
30 Day Average Volume 751,013
Price/Book (mrq) 6.1493
Price/Sale (ttm) 15.1269
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACRX

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. The Company's solutions are designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.

Adrian AdamsChairmanRichard A KingPresident/CEO
Timothy E Morris "Tim"Chief Financial OfficerPamela P PalmerChief Medical Officer/Co-Founder
More Company Profile & Key Executives for ACRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil